Natco Pharma Limited-RE
₹25.95▲ +1.15 (+4.64%)
NATCO-RE·NSE·Healthcare
Market Cap
44.10 Cr
PE Ratio
—
Volume
4,45,681
Day High - Low
28.00 - 21.00
52W High-Low
43.95 - 20.25
₹25.95▲ +1.15 (+4.64%)
Market Cap44.10 Cr
PE Ratio—
Volume4,45,681
Day High - Low28.00 - 21.00
52W High-Low43.95 - 20.25
Natco Pharma Limited-RE (NATCO-RE): company summary
Natco Pharma Limited-RE (NATCO-RE) is a micro-cap Healthcare company valued at ₹44 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Natco Pharma Limited-RE (NATCO-RE) is a micro-cap Healthcare company valued at ₹44 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Recent price move
- Natco Pharma Limited-RE last traded at ₹25.95, up 4.64% on the day.
- Things to watch
- The price sits 41% below its 52-week high.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
—/10
Not scored
Fair Value
Sign in to see
ROE
—
P/E
—
Debt / Equity
—
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Insufficient data
Price performance
Day₹21.00
₹28.00
52W₹20.25
₹43.95
DocStoX take
We do not have enough data on this company to score it — only 2 of 5 measures could be assessed. Rather than publish a number built on that, we are showing none.
DocStoX score
Low confidence—
No score
Quality
No data
No profitability data
Valuation
No data
No valuation multiples
Growth
No data
No multi-year history
Risk
Moderate
₹44 cr market cap
Momentum
Weak
24% of 52-week range
Only 2 of 5 measures could be assessed — too little to score this company honestly.
At a glance
Market Cap
₹44 Cr
52W High / Low
₹44 / ₹20
Dividend Yield
—
Promoter Holding
—
EPS (TTM)
—
Book Value
—
Key highlights
- Momentum is weak (1.3/10)
- Near the bottom of its 52-week range (24%)
0 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Natco Pharma Limited-RE’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Natco Pharma Limited-RE peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Natco Pharma Limited-RE with peers
Natco Pharma Limited-RE vs Sun Pharmaceutical Industries LimitedNatco Pharma Limited-RE vs Divi's Laboratories LimitedNatco Pharma Limited-RE vs Torrent Pharmaceuticals LimitedNatco Pharma Limited-RE vs Apollo Hospitals Enterprise LimitedNatco Pharma Limited-RE vs Zydus Lifesciences LimitedNatco Pharma Limited-RE vs Laurus Labs Limited
Related tools & concepts
Value Natco Pharma Limited-RE with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing